ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,064.20
0.91%
Dow Jones
38,225.66
0.85%
US Dollar vs MXN
16.9697
-0.02%
Brent Oil
83.80
0.20%
Bitcoin
59,516.28
0.67%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Better Therapeutics Inc (BTTX)

  7. Better Therapeutics Inc (BTTX) Noticias

BTTX Better Therapeutics Inc

0.0446
0.00 (0.00%)
01 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Better Therapeutics Inc BTTX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 0.0446 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.0446 0.0446
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
14/3/202408:38BWBetter Therapeutics Announces it will Seek Strategic..
11/3/202408:01EDGAR2Form 8-K - Current report
05/3/202408:25BWBetter Therapeutics Announces an Innovative Partnership with..
04/3/202408:25BWBetter Therapeutics Announces Acceptance of Late Breaking..
04/3/202407:51EDGAR2Form 8-K - Current report
01/3/202405:08EDGAR2Form RW - Registration Withdrawal Request
20/2/202408:25BWBetter Therapeutics Receives FDA Breakthrough Device..
12/2/202415:28EDGAR2Form SC 13D/A - General statement of acquisition of..
06/2/202408:43BWBetter Therapeutics Signs Rebate Agreement with One of the..
06/2/202408:02EDGAR2Form S-1/A - General form for registration of securities..
25/1/202415:30EDGAR2Form SC 13D/A - General statement of acquisition of..
23/1/202416:22EDGAR2Form D - Notice of Exempt Offering of Securities
17/1/202408:28BWBetter Therapeutics Announces Publication of..
10/1/202406:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
08/1/202415:42EDGAR2Form 8-K - Current report
04/1/202413:00BWBetter Therapeutics and Glooko Announce Partnership to..
02/1/202406:45BWBetter Therapeutics Announces Submission for FDA..
28/12/202320:23EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
21/12/202316:21EDGAR2Form S-1/A - General form for registration of securities..
20/12/202316:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202316:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202316:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202316:24EDGAR2Form S-1 - General form for registration of securities under..
13/12/202316:06EDGAR2Form 8-K - Current report
07/12/202319:09EDGAR2Form 3 - Initial statement of beneficial ownership of..
30/11/202315:10EDGAR2Form 8-K - Current report
28/11/202306:45BWBetter Therapeutics Strengthens Financial Position Through..
20/11/202316:08EDGAR2Form 8-K - Current report
14/11/202306:00BWFrost & Sullivan Honors Better Therapeutics with the 2023..
09/11/202306:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202306:03EDGAR2Form 8-K - Current report
09/11/202306:00BWBetter Therapeutics Reports Third Quarter 2023 Financial..
08/11/202306:30BWBetter Therapeutics to Release Third Quarter 2023 Financial..
30/10/202315:14EDGAR2Form 8-K - Current report
27/10/202315:26EDGAR2Form S-1/A - General form for registration of securities..
26/10/202306:55BWBetter Therapeutics to Participate in the American College..
16/10/202306:55BWBetter Therapeutics Announces Launch of AspyreRxTM to Treat..
16/10/202306:22EDGAR2Form DEF 14A - Other definitive proxy statements
12/10/202315:17EDGAR2Form S-3/A - Registration statement under Securities Act of..
11/10/202306:55BWBetter Therapeutics Announces New Data Highlighting..
06/10/202315:15EDGAR2Form PRE 14A - Other preliminary proxy statements
05/10/202306:45BWBetter Therapeutics Announces Publication of LivVita Liver..
28/9/202315:16BWBetter Therapeutics Completes Enrollment in Real-World..
25/8/202315:26EDGAR2Form S-3/A - Registration statement under Securities Act of..
14/8/202315:02EDGAR2Form SC 13D/A - General statement of acquisition of..
09/8/202315:37EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/8/202315:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202315:07EDGAR2Form 8-K - Current report
09/8/202315:03BWBetter Therapeutics Reports Second Quarter 2023 Financial..
02/8/202316:30BWBetter Therapeutics to Release Second Quarter 2023 Financial..

Su Consulta Reciente

NASDAQ
BTTX
Better Therapeutics
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados